Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#1 / 200 Total
VOR - Vor Biopharma Inc - Stock Price Chart
TickerVOR [NASD]
CompanyVor Biopharma Inc
CountryUSA
IndustryBiotechnology
Market Cap333.64MEPS (ttm)-1.51
P/E-EPS this Y56.45%
Forward P/E-EPS next Y36.23%
PEG-EPS past 5Y-38.02%
P/S-EPS next 5Y18.66%
P/B5.05EPS Q/Q42.54%
Dividend-Sales Q/Q-
Insider Own38.49%Inst Own42.26%
Insider Trans-0.01%Inst Trans-5.65%
Short Float4.19%EarningsMay 08
Analyst Recom2.60Target Price1.18
Avg Volume16.10M52W Range0.13 - 2.04
Vor Biopharma, Inc. engages in developing cell therapies for treating cancer. It is a clinical-stage cell therapy company that combines a novel patient engineering approach with therapies to provide a single company solution for patients suffering from hematological malignancies. The company was founded by Aleks Radovic-Moreno and Siddhartha Mukherjee on December 30, 2015 and is headquartered in Cambridge, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ROBERT ANGOfficerJul 02 '25Proposed Sale1.7944,93680,435Jul 02 04:40 PM
ROBERT ANGOfficerJul 01 '25Proposed Sale1.7240,46869,613Jul 01 04:58 PM
ROBERT ANGOfficerJun 30 '25Proposed Sale1.7340,62770,289Jun 30 05:15 PM
Attar Eyal C.CHIEF MEDICAL OFFICERFeb 13 '25Sale1.422,2273,162126,625Feb 18 04:20 PM
EYAL ATTAR OfficerFeb 13 '25Proposed Sale1.382,2273,073Feb 13 04:32 PM
IPA - ImmunoPrecise Antibodies Ltd - Stock Price Chart
TickerIPA [NASD]
CompanyImmunoPrecise Antibodies Ltd
CountryUSA
IndustryBiotechnology
Market Cap74.60MEPS (ttm)-1.13
P/E-EPS this Y41.11%
Forward P/E-EPS next Y82.54%
PEG-EPS past 5Y-11.23%
P/S4.28EPS next 5Y-
P/B4.30EPS Q/Q-447.09%
Dividend-Sales Q/Q-5.89%
Insider Own13.30%Inst Own8.65%
Insider Trans0.00%Inst Trans105.81%
Short Float3.50%EarningsMar 28/b
Analyst Recom1.00Target Price4.07
Avg Volume1.97M52W Range0.27 - 1.31
ImmunoPrecise Antibodies Ltd. is a techbio company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. It owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges. The company was founded by Robert Beecroft on November 22, 1983 and is headquartered in Austin, TX.
ABVC - ABVC BioPharma Inc - Stock Price Chart
TickerABVC [NASD]
CompanyABVC BioPharma Inc
CountryUSA
IndustryBiotechnology
Market Cap67.76MEPS (ttm)-0.14
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y27.39%
P/S132.86EPS next 5Y-
P/B11.35EPS Q/Q86.06%
Dividend-Sales Q/Q-100.00%
Insider Own14.33%Inst Own1.69%
Insider Trans0.00%Inst Trans-58.04%
Short Float3.49%Earnings-
Analyst Recom3.00Target Price20.20
Avg Volume356.46K52W Range0.40 - 3.12
ABVC BioPharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development of new drugs and medical devices. The firm's product pipeline includes ABV-1501, which is a combination therapy for triple negative breast cancer, ABV-1504, which is a botanical reuptake inhibitor that targets norepinephrine, ABV-1505 for treating attention deficit hyperactivity disorder, ABV-1702 to treat myelodysplastic syndromes, ABV-1703 for Pancreatic Cancer, ABV-1601 for treating depression in cancer patients, ABV-1701, which is a vitreous substitute for vitrectomy, ABV-2001, and ABV-2002. The company was founded in 1990 and is headquartered in Fremont, CA.
PRPO - Precipio Inc - Stock Price Chart
TickerPRPO [NASD]
CompanyPrecipio Inc
CountryUSA
IndustryDiagnostics & Research
Market Cap21.14MEPS (ttm)-2.09
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y42.48%
P/S1.06EPS next 5Y-
P/B1.80EPS Q/Q59.65%
Dividend-Sales Q/Q43.62%
Insider Own15.33%Inst Own7.44%
Insider Trans6.96%Inst Trans49.98%
Short Float0.44%EarningsMay 15/a
Analyst Recom1.00Target Price19.00
Avg Volume13.69K52W Range3.90 - 12.45
Precipio, Inc.is a cancer diagnostics and reagent technology company, which provides diagnostic products and services to the oncology market. Its products include ICP, HemeScreen, and IV-Cell, and services include primary diagnostic, SmartPath, SmartGen, HemeScreen Panel, and ICE COLD-PCR. The company was founded on March 6, 1997 and is headquartered in New Haven, CT.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SANDBERG RICHARD ADirectorMay 30 '25Buy10.001,39913,98640,175May 30 04:31 PM
SANDBERG RICHARD ADirectorMay 27 '25Buy9.8010199038,776May 28 04:37 PM
SANDBERG RICHARD ADirectorMay 22 '25Buy9.335004,66538,675May 27 04:05 PM
SANDBERG RICHARD ADirectorMay 21 '25Buy9.278,03574,47438,175May 22 05:01 PM
SANDBERG RICHARD ADirectorMay 20 '25Buy8.474,25136,00630,140May 21 04:34 PM
VIOT - Viomi Technology Co Ltd ADR - Stock Price Chart
TickerVIOT [NASD]
CompanyViomi Technology Co Ltd ADR
CountryChina
IndustryFurnishings, Fixtures & Appliances
Market Cap89.68MEPS (ttm)0.13
P/E20.43EPS this Y154.83%
Forward P/E20.29EPS next Y18.18%
PEG-EPS past 5Y-26.82%
P/S0.28EPS next 5Y-
P/B0.91EPS Q/Q-537.53%
Dividend-Sales Q/Q-38.62%
Insider Own0.13%Inst Own3.68%
Insider Trans0.00%Inst Trans-0.58%
Short Float0.01%EarningsMay 15/b
Analyst Recom-Target Price4.00
Avg Volume403.66K52W Range0.82 - 2.38
Viomi Technology Co., Ltd. is a holding company, which engages in the development, manufacture, and sell of IoT products, including smart water purification systems. Its products include refrigerators, oven steamers, dishwashers, range hoods, and gas stoves. The company was founded by Xiao Ping Chen in May 2014 and is headquartered in Guangzhou, China.
TZUP - Thumzup Media Corp - Stock Price Chart
TickerTZUP [NASD]
CompanyThumzup Media Corp
CountryUSA
IndustryAdvertising Agencies
Market Cap97.00MEPS (ttm)-0.67
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-437.23%
P/S-EPS next 5Y-
P/B34.29EPS Q/Q-536.11%
Dividend-Sales Q/Q-62.72%
Insider Own70.09%Inst Own1.04%
Insider Trans0.21%Inst Trans-12.48%
Short Float8.36%Earnings-
Analyst Recom-Target Price-
Avg Volume203.91K52W Range2.02 - 9.99
Thumzup Media Corp. engages in the development of social media branding and marketing solutions. The firm offers the Thumzup platform, which utilizes a programmatic advertiser dashboard coupled with a consumer-facing app to enable individuals to get paid cash for posting about participating advertisers on social media outlets. It also allows advertisers to programmatically customize campaigns. The company was founded by Robert Steele and Daniel Lupinelli on October 27, 2020 and is headquartered in Los Angeles, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Massey Joanna D.DirectorMay 29 '25Option Exercise4.0010,00040,00020,592May 29 05:05 PM
HAAG ROBERT LDirectorMay 29 '25Option Exercise4.0012,50050,000312,476May 29 05:05 PM
Dietrich IsaacChief Financial OfficerMar 18 '25Buy3.741,3004,86225,622Mar 19 02:29 PM
Dietrich IsaacChief Financial OfficerMar 19 '25Buy3.701,1184,13726,740Mar 19 02:29 PM
HAAG ROBERT LDirectorMar 14 '25Buy3.615,00018,0265,125Mar 17 09:20 AM
BSGM - Biosig Technologies Inc - Stock Price Chart
TickerBSGM [NASD]
CompanyBiosig Technologies Inc
CountryUSA
IndustryMedical Devices
Market Cap315.25MEPS (ttm)-0.62
P/E-EPS this Y66.67%
Forward P/E-EPS next Y32.00%
PEG-EPS past 5Y46.11%
P/S10508.33EPS next 5Y-
P/B107.51EPS Q/Q62.27%
Dividend-Sales Q/Q-100.00%
Insider Own39.71%Inst Own27.68%
Insider Trans0.00%Inst Trans8.13%
Short Float7.90%EarningsMay 19
Analyst Recom1.00Target Price10.00
Avg Volume821.60K52W Range0.23 - 10.73
Jul-07-25 06:41PM BioSig Technologies, Inc. and Streamex Exchange Corporation Announce Definitive Agreements for up to $1.1B USD in Growth Financing to Launch Gold Backed Treasury Management Strategy and to Rapidly Expand RWA Tokenization for the Commodities Markets (Business Wire) +10.95%
Jun-09-25 10:30AM BioSig & Streamex Appoint Parcl Co-Founders Trevor Bacon and Kellan Grenier as Strategic Advisors (GlobeNewswire) -14.05%
Jun-04-25 08:25AM BioSig & Streamex Appoint Co-Founder of the Osisko Group & Mining Visionary, Sean Roosen as Strategic Advisor (GlobeNewswire) -10.59%
May-28-25 06:45PM CORRECTION: Streamex and BioSig Appoint Former OppenheimerFunds and Wafra Inc Executive, Mitch Williams, CFA, as Chief Investment Officer (CIO) (GlobeNewswire) -8.74% -13.68%
01:46PM BioSig Appoints Former OppenheimerFunds and Wafra Inc Executive, Mitch Williams, CFA, as Chief Investment Officer (GlobeNewswire)
01:07PM Streamex and BioSig Announce the Successful Closing of Share Exchange Transaction and Executive Leadership Changes Bringing a First-Mover Real World Asset Tokenization Company to the Nasdaq (GlobeNewswire)
May-27-25 08:20AM BioSig Technologies signs definitive share exchange agreement with Streamex (TipRanks) +21.40%
May-26-25 12:42PM BioSig Stock Surges Following Share Exchange Deal With Streamex (Zacks)
May-25-25 06:31PM BioSig Technologies, Inc. (BSGM) Turns to Tokenization with Streamex Acquisition (Insider Monkey)
May-23-25 07:56PM BioSig Technologies, Inc. Signs Definitive Share Exchange Agreement with Streamex Exchange Corp. to Launch First-Mover Real-World Asset (RWA) Tokenization Company Bringing Commodity Markets On-Chain. (GlobeNewswire) +24.24% +21.40%
BioSig Technologies, Inc. is a medical technology company, which engages in the development of a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of electrocardiographic and intra-cardiac signals. Its product PURE EP System is a computerized system intended for acquiring, digitizing, amplifying, filtering, measuring and calculating, displaying, recording, and storing of electrocardiographic and intra-cardiac signals for patients undergoing electrophysiology procedures. The company was founded by Kenneth L. Londoner on February 24, 2009 and is headquartered in Los Angeles, CA.
APYX - Apyx Medical Corp - Stock Price Chart
TickerAPYX [NASD]
CompanyApyx Medical Corp
CountryUSA
IndustryMedical Devices
Market Cap97.51MEPS (ttm)-0.55
P/E-EPS this Y41.85%
Forward P/E-EPS next Y-11.66%
PEG-EPS past 5Y-2.68%
P/S2.06EPS next 5Y20.65%
P/B9.28EPS Q/Q53.41%
Dividend-Sales Q/Q-7.95%
Insider Own14.89%Inst Own41.79%
Insider Trans0.00%Inst Trans0.17%
Short Float0.66%EarningsMay 08/b
Analyst Recom2.33Target Price4.00
Avg Volume201.75K52W Range0.76 - 2.35
Apyx Medical Corp. operates as an energy-based medical technology company. The firm engages in developing, manufacturing, and marketing a range of electrosurgical products and technologies, as well as related medical products used by the offices of doctors, surgery centers, and hospitals worldwide. It operates through the following segments: Advanced Energy and Original Equipment Manufacturer (OEM). The company was founded by Andrew Makrides in 1978 and is headquartered in Clearwater, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HILL MATTHEW CChief Financial OfficerAug 13 '24Buy1.135,3366,0307,836Aug 13 06:56 PM
ZVRA - Zevra Therapeutics Inc - Stock Price Chart
TickerZVRA [NASD, RUT]
CompanyZevra Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap616.24MEPS (ttm)-1.89
P/E-EPS this Y88.27%
Forward P/E17.24EPS next Y344.39%
PEG-EPS past 5Y29.64%
P/S15.18EPS next 5Y-
P/B15.02EPS Q/Q85.60%
Dividend-Sales Q/Q495.65%
Insider Own1.18%Inst Own65.35%
Insider Trans-16.77%Inst Trans6.65%
Short Float8.72%EarningsMay 13/a
Analyst Recom1.00Target Price23.29
Avg Volume661.18K52W Range4.20 - 10.03
Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Thompson RahsaanChief Legal & ComplianceJun 26 '25Sale9.2124,000221,00442,666Jun 30 05:02 PM
RAHSAAN THOMPSONOfficerJun 26 '25Proposed Sale9.3324,000223,920Jun 26 04:25 PM
Watton Corey MichaelDirectorMar 28 '25Buy7.843002,3521,800Mar 31 08:05 PM
Bode John BDirectorMar 19 '25Buy7.9610,00079,62440,000Mar 21 04:06 PM
Sangiovanni Timothy J.SVP, Finance & Corp ControllerFeb 13 '25Sale7.863,00023,58816,341Feb 14 05:57 PM
UUU - Universal Security Instruments, Inc - Stock Price Chart
TickerUUU [AMEX]
CompanyUniversal Security Instruments, Inc
CountryUSA
IndustrySecurity & Protection Services
Market Cap8.48MEPS (ttm)-0.55
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y21.74%
P/S0.38EPS next 5Y-
P/B2.04EPS Q/Q-1016.29%
Dividend-Sales Q/Q18.91%
Insider Own19.89%Inst Own22.86%
Insider Trans2.22%Inst Trans0.16%
Short Float0.68%Earnings-
Analyst Recom-Target Price-
Avg Volume44.58K52W Range1.11 - 3.50
Universal Security Instruments, Inc. designs and markets safety products consisting primarily of smoke alarms, carbon monoxide alarms and related products. Its products include Smoke and Fire Alarms, Carbon Monoxide Alarms, Combo Smoke, CO & Gas Alarms, 10 Year Sealed Battery Alarms, Home Safety & Security, and Alarm Accessories. The company also markets products to the electrical distribution trade through its subsidiaries, which include electrical and lighting distributors as well as manufactured housing companies. The company was founded by Stephen C. Knepper and Michael L. Kovens in 1969 and is headquartered in Owings Mills, MD.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
AULT MILTON C IIIDirectorJun 04 '25Buy3.025,00015,0758,725Jun 06 09:00 PM
AULT MILTON C IIIDirectorMay 30 '25Buy2.395,00011,9685,000Jun 03 04:30 PM
1234561020